These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28962344)

  • 1. Reduced kidney levels of lysophosphatidic acids in rats after chronic administration of aristolochic acid: Its possible protective role in renal fibrosis.
    Tsutsumi T; Yamakawa S; Ishihara A; Yamamoto A; Tanaka T; Tokumura A
    Toxicol Rep; 2015; 2():121-129. PubMed ID: 28962344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced rat plasma lysophosphatidylglycerol or lysophosphatidic acid level as a biomarker of aristolochic acid-induced renal and adipose dysfunctions.
    Tsutsumi T; Okamoto Y; Yamakawa S; Bingjun C; Ishihara A; Tanaka T; Tokumura A
    Life Sci; 2016 Jul; 157():208-216. PubMed ID: 27267499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
    Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
    Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats.
    Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A
    Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered ovarian tissue level of lysophosphatidic acid and mRNA expressions of its metabolic enzymes and receptors in rats received gonadotropin-hyperstimulation.
    Yamamoto-Mikami A; Tanaka Y; Tsutsumi T; Kuwahara A; Tokumura A
    Reprod Biol; 2024 Mar; 24(1):100849. PubMed ID: 38306852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential protective role of lysophospholipid mediators in nephrotoxicity induced by chronically exposed cadmium.
    Tsutsumi T; Ishihara A; Yamamoto A; Asaji H; Yamakawa S; Tokumura A
    Food Chem Toxicol; 2014 Mar; 65():52-62. PubMed ID: 24361405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular and intracellular productions of lysophosphatidic acids and cyclic phosphatidic acids by lysophospholipase D from exogenously added lysophosphatidylcholines to cultured NRK52E cells.
    Tsutsumi T; Kawabata K; Yamazaki N; Tsukigawa K; Nishi H; Tokumura A
    Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159349. PubMed ID: 37295607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
    Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
    Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA1 receptor activation promotes renal interstitial fibrosis.
    Pradère JP; Klein J; Grès S; Guigné C; Neau E; Valet P; Calise D; Chun J; Bascands JL; Saulnier-Blache JS; Schanstra JP
    J Am Soc Nephrol; 2007 Dec; 18(12):3110-8. PubMed ID: 18003779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease.
    Hirata T; Smith SV; Takahashi T; Miyata N; Roman RJ
    J Pharmacol Exp Ther; 2021 Feb; 376(2):240-249. PubMed ID: 33277348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.
    Xian Z; Tian J; Zhao Y; Yi Y; Li C; Han J; Zhang Y; Wang Y; Wang L; Liu S; Pan C; Liu C; Wang D; Meng J; Tang X; Wang F; Liang A
    Phytomedicine; 2023 Jun; 114():154815. PubMed ID: 37062136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective role of relaxin in a mouse model of aristolochic acid nephropathy.
    Yang X; Thorngren D; Chen Q; Wang M; Xie X
    Biomed Pharmacother; 2019 Jul; 115():108917. PubMed ID: 31060002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Na+,K+-ATPase activity by phospholipase A2 and several lysophospholipids: possible role of phospholipase A2 in noradrenaline release from cerebral cortical synaptosomes.
    Nishikawa T; Tomori Y; Yamashita S; Shimizu S
    J Pharm Pharmacol; 1989 Jul; 41(7):450-8. PubMed ID: 2570849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis of altered proteins in kidney of mice with aristolochic acid nephropathy using the fluorogenic derivatization-liquid chromatography-tandem mass spectrometry method.
    Lin CE; Chang WS; Lee JA; Chang TY; Huang YS; Hirasaki Y; Chen HS; Imai K; Chen SM
    Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29088495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction.
    Tsutsumi T; Adachi M; Nikawadori M; Morishige J; Tokumura A
    Life Sci; 2011 Aug; 89(5-6):195-203. PubMed ID: 21693124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of silicosis formation by lysophosphatidic acid and its receptors.
    Cong C; Mao L; Zhang Y; Zhao Z; Xu X; Zhao J
    Exp Lung Res; 2014 Sep; 40(7):317-26. PubMed ID: 24926730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids.
    Kurano M; Dohi T; Nojiri T; Kobayashi T; Hirowatari Y; Inoue A; Kano K; Matsumoto H; Igarashi K; Nishikawa M; Miyauchi K; Daida H; Ikeda H; Aoki J; Yatomi Y
    BBA Clin; 2015 Dec; 4():92-8. PubMed ID: 26675681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of BMP-7 against aristolochic acid-induced renal tubular epithelial cell injury.
    Wang Z; Zhao J; Zhang J; Wei J; Zhang J; Huang Y
    Toxicol Lett; 2010 Oct; 198(3):348-57. PubMed ID: 20696222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary lysophopholipids are increased in diabetic patients with nephropathy.
    Saulnier-Blache JS; Feigerlova E; Halimi JM; Gourdy P; Roussel R; Guerci B; Dupuy A; Bertrand-Michel J; Bascands JL; Hadjadj S; Schanstra JP
    J Diabetes Complications; 2017 Jul; 31(7):1103-1108. PubMed ID: 28506691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.